Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells

Clinical and Experimental Immunology

Volumn 176, Issue 3, 2014, Pages 473-484

  Niu, J ^a   Yue, W ^a   Song, Y ^a   Zhang, Y ^b   Qi, X ^c   Wang, Z ^a   Liu, B ^a   Shen, H ^d   Hu, X ^e  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Interleukin 10; Liver transplantation; Mesenchymal stem cells (MSCs); Transplantation tolerance

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENETIC ENGINEERING; GENETIC TRANSDUCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL TIME; TIME;

INTERLEUKIN-10; LIVER TRANSPLANTATION; MESENCHYMAL STEM CELLS (MSCS); TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; LIVER; LIVER TRANSPLANTATION; MALE; MESENCHYMAL STROMAL CELLS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RATS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSDUCTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84899086867     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12283     Document Type: Article

References (43)

1. Yang YJ, Li LX, He Q etal. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation. Hepatobiliary Pancreat Dis Int 2007; 6:376-378.
2. Segers VF, Van RI, Andries LJ etal. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol 2006; 290:1370-1377.
3. Rojas M, Xu J, Woods CR etal. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2006; 33:145-152.
4. Oishi K, Noguchi H, Yukawa H etal. Differential ability of somatic stem cells. Cell Transplant 2009; 18:581-589.
5. Kuo TK, Ho JH, Lee OK. Mesenchymal stem cell therapy for nonmusculoskeletal diseases: emerging applications. Cell Transplant 2009; 18:1013-1028.
6. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8:726-736.
7. Karlsson H, Samarasinghe S, Ball LM etal. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood 2008; 112:532-541.
8. Liu XJ, Zhang JF, Sun B etal. Reciprocal effect of mesenchymal stem cell on experimental autoimmune encephalomyelitis is mediated by transforming growth factor-beta and interleukin-6. Clin Exp Immunol 2009; 158:37-44.
9. Wang Y, Zhang A, Ye Z etal. Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion. Transplant Proc 2009; 41:4352-4356.
10. Zuo Z, Wang C, Carpenter D etal. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation 2001; 71:686-691.
11. Tashiro H, Shinozaki K, Yahata H etal. Prolongation of liver allograft survival after interleukin-10 gene transduction 24-48 hours before donation. Transplantation 2000; 70:336-339.
12. Kanki-Horimoto S, Horimoto H, Mieno S etal. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 2006; 114:181-185.
13. Zhao YD, Courtman DW, Deng Y etal. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 2005; 96:442-450.
14. Zhang FG, Yao Y, Feng Y, Hua CG, Tang XF. Mesenchymal stem cells transduced by stromal cell-derived factor-1α augment ischemic free flaps' survival. Ann Plast Surg 2011; 66:92-97.
15. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery 1983; 93:64-69.
16. Siegel G, Schafer R, Dazzi F. The immunosuppressive properties of mesenchymal stem cells. Transplantation 2009; 87:45-49.
17. Demetris AJ, Batts KP, Dhillon AP etal. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25:658-663.
18. Harris RG, Herzog EL, Bruscia EM etal. Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 2004; 305:90-93.
19. Fujino M, Adachi K, Kawasaki M etal. Prolonged survival of rat liver allograft with adenoviral gene transfection of human immunodeficiency virus type 1 nef. Liver Transpl 2003; 9:805-813.
20. Knechtle SJ, Kwun J. Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 2009; 29:91-101.
21. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27:147-163.
22. Chandan G, Namita RC, Hugo J etal. Hepatocyte-based gene therapy. J Hepatobiliary Pancreat Surg 2000; 1:51-57.
23. Andreas H, Daniela W, Ulrich MB etal. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci USA 2009; 106:44-49.
24. Casiraghi F, Azzollini N, Cassis P etal. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181:3933-3946.
25. Popp FC, Eggenhofer E, Renner P etal. Mesenchymal stem cells can induce longterm acceptance of solid organ allografts in synergy with low-dose mycophenolate. Transpl Immunol 2008; 20:55-60.
26. Keyser KA, Beagles KE, Kiem HP. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 2007; 16:555-562.
27. Li H, Guo ZK, Li XS etal. Functional and phenotypic alteration of intrasplenic lymphocytes affected by mesenchymal stem cells in a murine allosplenocyte transfusion model. Cell Transplant 2007; 16:85-95.
28. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11:7-13.
29. + regulatory T cells. Transl Res 2009; 153:60-70.
30. Long E, Wood KJ. Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation 2009; 88:1050-1056.
31. + regulatory T cells. Am J Transplant 2008; 8:1639-1651.
32. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523-532.
33. Leung S, Liu X, Fang L etal. The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol 2010; 7:182-189.
34. Lee YK, Turner H, Maynard CL etal. Late developmental plasticity in the T helper 17 lineage. Immunity 2009; 30:92-107.
35. Weaver CT. Th17: the ascent of a new effector T-cell subset. Preface. Eur J Immunol 2009; 39:634-636.
36. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-1057.
37. Peck A, Mellins ED. Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin Immunol 2009; 132:295-304.
38. Darlington PJ, Boivin MN, Renoux C etal. Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: implication for multiple sclerosis. Ann Neurol 2010; 68:540-545.
39. Fábrega E, López-Hoyos M, San SD etal. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl 2009; 15:629-633.
40. Vanaudenaerde BM, Dupont LJ, Wuyts WA etal. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27:779-787.
41. Yoshida S, Haque A, Mizobuchi T etal. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006; 6:724-735.
42. Herzog EL, Van AJ, Hu B etal. Threshold of lung injury required for the appearance of marrow-derived lung epithelia. Stem Cells 2006; 24:1986-1992.
43. Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ Res 2006; 98:1002-1013.